In ALLG News Edition 6, you can read about progress in blood cancer treatment, the future of clinical trials, the role trial coordinators play in improving cancer care, and learn the latest in [...]
Life Member and Order of Australia recipient, Professor Mark Hertzberg was recently appointed as our new Board Director.
On Friday 27 October we wrapped up our bumper 50th Anniversary ALLG Scientific Meeting.
It’s a very special year at the ALLG. Our collaborative success in clinical trials has laid the foundations for a brighter future for blood cancer patients for over 50 years. There’s a lot to [...]
Calling blood cancer patients and carers in Sydney! Would you like to know more from the experts about wellbeing throughout your treatment journey? Or hear how clinical trials can help you?
September is Blood Cancer Month. You can read about ALLG's "5 decades of impact" in blood cancer clinical trials, and the "best results we have ever seen" in Advanced Hodgkin lymphoma from one of [...]
Fourth edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
The ALLG's Laboratory Science research is helping determine which patients benefit from targeted therapy for their blood cancer. You can read about this and more in our latest quarterly [...]
The HeSANDA platform is a catalogue of research metadata from clinical trials conducted across Australia that enables researchers to access and share data from health studies. Led by the [...]
Congratulations to ALLG Life Member Dr Ruth Spearing who has been honoured in the 2023 King's Birthday New Zealand and Coronation Honours! Ruth has been made a Companion of the New Zealand Order [...]
Two ALLG clinical trials, ALL08 BLAM and NHL29 IRIC have been accepted as abstracts with poster presentations at prestigious European scientific conferences.
ALLG has featured in The Limbic with our Scientific Advisory Committee Chair, Prof Judith Trotman, interviewed about our five decades of impact.
It's our pleasure to share with you the third Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
Sir Sam Neill – New Zealand actor and blood cancer survivor supports the ALLG’s concerns of proposed NZ bill affecting clinical trials
Sir Sam Neill, New Zealand (NZ) actor and blood cancer survivor supports the ALLG’s concerns of proposed NZ bill affecting clinical trials.
ALLG has featured in the Herald Sun and The Advertiser newspapers with "World first cancer trial" about a novel way to identify and treat patients with acute myeloid leukaemia (AML) before they [...]
Prof Hang Quach, Chair of ALLG's Myeloma Scientific Working Party talks about clinical trials in myeloma for better treatments…better lives.
Latest ‘State of the Nation: Blood Cancer in Australia’ report highlights progress and the actions still required to improve outcomes for patients.
Congratulations to ALLG Consumer Representative, Mr John Stubbs AM, who has been appointed a Member of the Order of Australia for ‘significant service to community health, particularly to people [...]
Teletrial program allowed Vesselin Petkov to take part in an ALLG clinical trial without being separated from his family
An Australian Teletrial Program (ATP) is working to improve access to clinical trials for people living in rural and regional parts of the country. Vesselin Petkov from Cairns [pictured with his [...]
Second edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
It's our pleasure to share with you the second Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
ALLG Member, Dr Ashley Ng, a WEHI Clinical Translational Research Fellow, has been awarded the prestigious Metcalf Prize for Stem Cell Research, for "Controlling rogue blood stem cells".
It's our pleasure to share with you the first ever Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
The ALLG has opened the first hospital site in Australia for a clinical trial that is a world first in acute myeloid leukaemia (AML) trials. The AMLM26 INTERCEPT study aims to radically change [...]
The ALLG trial BM12 CAST has been accepted for publication as an abstract at EHA. Congratulations to the Chief Investigators A/Prof David Curtis and Dr Sushrut Patil, and the trial team.